Spero Therapeutics, Inc. · NASDAQ:SPRO
Thomas Frank E received 10,000 Spero Therapeutics, Inc. shares as an award (Form 4)
Traded Jun 23, 2026 · Filed Jun 25, 2026
On Jun 23, 2026, Thomas Frank E (Director) received 10,000 Spero Therapeutics, Inc. shares as an award, leaving 85,000 shares. Filed Jun 25, 2026 (Form 4).
- Awarded
- 10,000 shares
- Holding after
- 85,000 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 23, 2026 | Common Stock | Award | 10,000 | 85,000 | Direct |